Nomenclature and Serology of HLA Class I and Class II Alleles

James McCluskey1, Carmel Kanaan2, Mary Diviney2

1 University of Melbourne and Australian Red Cross Blood Service, Melbourne, 2 Australian Red Cross Blood Service, Melbourne
Publication Name:  Current Protocols in Immunology
Unit Number:  Appendix A.1S
DOI:  10.1002/cpim.32
Online Posting Date:  August, 2017
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library


This overview presents nomenclature and serology information on human leucocyte antigens, or HLA molecules, which are encoded by a cluster of genes linked on the short arm of chromosome 6. This region is known as the major histocompatibility complex and codes for class I and class II molecules, which are distinguished from each other based upon their structure, tissue distribution, and source of peptide antigen, as well as upon their interactions with T cell subsets. © 2017 by John Wiley & Sons, Inc.

Keywords: human leucocyte antigens; HLA; major histocompatibility complex; MHC; HLA class I; HLA class II

PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • MHC Class I Molecules
  • MHC Class II Molecules
  • Serological Definition of Polymorphism in HLA Molecules: Historical Nomenclature
  • Supertypic Bw4 and Bw6 Serological Specificities
  • Principles of Nomenclature
  • Literature Cited
  • Figures
  • Tables
PDF or HTML at Wiley Online Library


PDF or HTML at Wiley Online Library



Literature Cited

Literature Cited
  Beck, S., & Trowsdale, J. (1999). Sequence organisation of the class II region of the human MHC. Immunological Reviews, 167, 201–210. doi: 10.1111/j.1600‐065X.1999.tb01393.x.
  Campbell, R. D., & Trowsdale, J. (1993). Map of the human MHC. Immunology Today, 14, 349–352. doi: 10.1016/0167‐5699(93)90234‐C.
  Herberg, J. A., Beck, S., & Trowsdale, J. (1998). TAPASIN, DAXX, RGL2, HKE2 and four new genes (BING 1, 3 to 5) form a dense cluster at the centromeric end of the MHC. Journal of Molecular Biology, 277, 839–857. doi: 10.1006/jmbi.1998.1637.
  Holdsworth, R., Hurley, C. K., Marsh, S. G. E., Lau, M., Noreen, H. J., Kempenich, J. H., … Maiers, M. (2009). The HLA dictionary 2008: A summary of HLA‐A, ‐B, ‐C, ‐DRB1/3/4/5, ‐DQB1 alleles and their association with serologically defined HLA‐A, ‐B, ‐C, ‐DR and ‐DQ antigens. Tissue Antigens, 73, 95–170. doi: 10.1111/j.1399‐0039.2008.01183.x.
  Kesmir, C., Nussbaum, A. K., Schild, H., Detours, V., & Brunak, S. (2002). Prediction of proteasomal cleavage motifs by neural networks. Protein Engineering, 15, 287–296. doi: 10.1093/protein/15.4.287.
  Little, A. M., & Parham, P. (1999). Polymorphism and evolution of HLA class I and II genes and molecules. Reviews in Immunogenetics, 1, 105–123.
  Madden, D. R. (1995). The three‐dimensional structure of peptide‐MHC complexes. Annual Review of Immunology, 13, 587–622. doi: 10.1146/annurev.iy.13.040195.003103.
  Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Bontrop, R. E., Dupont, B., Erlich, H. A., … Trowsdale, J. (2010). Nomenclature for factors of the HLA system. Tissue Antigens, 75, 291–455. doi: 10.1111/j.1399‐0039.2010.01466.x.
  Marsh, S. G., Parham, P., & Barber, L. D., & (2000). The HLA facts book. London: Academic Press.
  Natarajan, K., Li, H., Mariuzza, R. A., & Margulies, D. H. (1999). MHC class I molecules, structure and function. Reviews in Immunogenetics, 1, 32–46.
  Nielsen, M., Lundegaard, C., Lund, O., & Kesmir, C. (2005). The role of the proteasome in generating cytotoxic T cell epitopes: Insights obtained from improved predictions of proteasomal cleavage. Immunogenetics, 57(1‐2), 33–41. doi: 10.1007/s00251‐005‐0781‐7.
  Nussbaum, A. K., Kuttler, C., Hadeler, K. P., Rammensee, H. G., & Schild, H. (2001). Paproc: A prediction algorithm for proteasomal cleavages available on the WWW. Immunogenetics, 53, 87–94. doi: 10.1007/s002510100300.
  Parham, P., Lawlor, D. A., Salter, R. D., Lomen, C. E., Bjorkman, P. J., & Ennis, P. D. (1987). HLA ‐A, B, C: Pattern of polymorphism in peptide‐binding proteins. In B. Dupont (Ed.), Immunobiology of HLA: Immunogenetics and histocompatibility (Vol. 2, pp. 28–34). New York: Springer‐Verlag.
  Parker, K. C., Shields, M., DiBrino, M., Brooks, A., & Coligan, J. E. (1995). Peptide binding to MHC class I molecules: Implications for antigenic peptide prediction. Immunologic Research, 14, 34–57. doi: 10.1007/BF02918496.
  Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A., & Stevanovic, S. (1999). SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics, 50, 213–219. doi: 10.1007/s002510050595.
  Robinson, J., Halliwell, J. A., Hayhurst, J. H., Flicek, P., Parham, P., & Marsh, S. G. E. (2015). The IPD and IPD‐IMGT/HLA database: Allele variant databases. Nucleic Acids Research, 43, D423–431. doi: 10.1093/nar/gku1161.
  Shiina, T., Tamiya, G., Oka, A., Takishima, N., & Inoko, H. (1999). Genome sequencing analysis of the 1.8 Mb entire human MHC class I region. Immunological Reviews, 167, 193–199. doi: 10.1111/j.1600‐065X.1999.tb01392.x.
PDF or HTML at Wiley Online Library